Related by context. All words. (Click for frequent words.) 72 MAbs 71 lentiviral vectors 71 monoclonal antibodies 69 humanized monoclonal antibodies 69 mAb 68 humanized antibody 68 dAbs 68 A3 adenosine receptor 68 humanized antibodies 68 nanoviricides 68 therapeutic monoclonal antibodies 68 glycosylation profile 68 glycosylated 68 DNA plasmids 68 antibody 68 antisense oligonucleotides 68 peptide antigens 68 PEGylated 68 viral vectors 67 monoclonal 67 siRNA sequences 67 XmAb# 67 synthetic peptides 67 chimeric protein 67 monoclonal antibodies MAbs 67 recombinant antibodies 67 NEUGENE 67 IMA# 67 Nanobodies ® 67 antiviral therapies 67 Monoclonal antibodies 66 cytotoxics 66 immunogens 66 viral proteins 66 PARP inhibitors 66 antibodies 66 cancer immunotherapies 66 molecularly targeted 66 tumor antigens 66 JAK3 66 MEK inhibitors 66 CXCR4 receptor 66 anticancer therapies 66 SERMs 66 subunit vaccines 66 antisense compounds 66 nucleosides 66 antiviral compounds 65 aptamers 65 naturally occurring antibodies 65 monoclonal antibody mAb 65 affinity antibodies 65 immunotoxins 65 monoclonals 65 immunotoxin 65 prophylactic vaccines 65 multitargeted 65 anti CD# antibodies 65 OncoVEX 65 polyclonal antibodies 65 polyclonal 65 MAb 65 PI3K inhibitors 65 chemotherapeutics 65 proteasome inhibitors 65 VLPs 65 influenza subtypes 65 subunit vaccine 65 IMPDH 65 nucleoside analogues 65 proteasome inhibitor 65 monoclonal antibodies mAbs 65 biodegradable nanoparticles 64 biologic therapeutics 64 anti CD3 64 fusion proteins 64 TNFa 64 siRNA therapeutic 64 small molecule inhibitors 64 anti idiotype 64 molecularly targeted therapies 64 viral genomes 64 GRNVAC1 64 defensins 64 HCV protease inhibitors 64 heterologous 64 kinase inhibitors 64 immune modulating 64 Anticalins 64 polymerase inhibitors 64 delafloxacin 64 ESBA# 64 Th2 cytokines 64 antibody fragment 64 siRNA therapeutics 64 alpha interferon 64 transfection reagents 64 outer membrane proteins 64 oncolytic 64 Factor VIIa 64 Tarvacin Anti Viral 64 conserved sequences 64 microtubule inhibitor 64 BiTE 64 interferon IFN 64 transgenic rats 64 epithelial tumors 64 tumor antigen 64 cytotoxic agents 64 immunomodulators 64 adenoviral 64 miR #a [002] 64 antisense RNA 63 viral antigens 63 Nanobody ® 63 rxRNA compounds 63 busulfan 63 hematopoietic cells 63 virosomes 63 Interferon alpha 63 replicase 63 Nanobodies 63 integrin receptors 63 secreted proteins 63 Sym# 63 effector functions 63 plasma proteins 63 LNP formulations 63 histone deacetylase HDAC 63 AEG# 63 nucleoside analogs 63 nanomolar 63 cytostatic 63 HER2 receptor 63 IgG1 63 murine antibodies 63 FLT3 63 lentiviral vector 63 JAK inhibitors 63 CD# antibodies 63 Gleevec resistant 63 M. pneumoniae 63 cathepsins 63 XmAb 63 delta isoform 63 monoclonal antibody 63 CCX# 63 novel peptide 63 enveloped viruses 63 replicon 63 oncolytic viruses 63 anticancer therapeutics 63 DermaVir 63 radezolid 63 adenovirus vector 63 antibody fragments 63 anticancer agents 63 conjugate vaccines 63 recombinants 63 live attenuated vaccines 63 VDAs 63 interferon lambda 63 Chemokine Receptor 63 Tarvacin 63 adenovirus vectors 63 CD4 + T lymphocytes 63 IgGs 63 macrocycles 63 OMP #M# 62 tubulin inhibitor 62 plasmid DNA vaccine 62 viral antigen 62 small molecule activators 62 pharmacokinetic interactions 62 antiangiogenesis 62 peptides 62 virulence genes 62 monoclonal antibody therapies 62 renin inhibitors 62 NS4A 62 CD# antibody [001] 62 TLR agonists 62 GPCR targets 62 beta interferons 62 splice variants 62 virions 62 inhibit viral replication 62 mimetics 62 camptothecin 62 ENMD # 62 lymphoid tumors 62 miRNA molecules 62 NS5A 62 polyclonal antibody 62 antiangiogenic agents 62 Anticalins ® 62 transmembrane proteins 62 nanocarriers 62 biologic therapies 62 bispecific 62 UsiRNAs 62 Litx 62 HBV vaccine 62 TLR8 62 neutralizing antibody 62 ELISPOT assay 62 butyrylcholinesterase 62 therapeutic monoclonal antibody 62 oncoproteins 62 p# inhibitors 62 radionuclide therapy 62 trivalent vaccine 62 poxvirus 62 siRNA 62 interferons 62 CEQ# 62 Smac mimetic 62 cleavable linker 62 Anticalins R 62 DXL# 62 RNA sequences 62 immune stimulatory 62 antisense drugs 62 Onconase 62 attenuated strain 62 chemical entities NCEs 62 NF kB pathway 62 MyVax R 62 protein therapeutics 62 prodrugs 62 echinocandins 62 immunological responses 62 embryonic stem cells ESCs 62 MVA BN R 62 vascular disrupting agents 62 JVRS 62 fusion inhibitor 62 c MET 62 short hairpin RNAs 62 daptomycin 62 superantigens 62 L asparaginase 62 BRAF kinase 62 antisense inhibitors 61 anti angiogenic drugs 61 CTLs 61 C5aR 61 JAK2 inhibitors 61 inhibit replication 61 inhibit EGFR 61 molecular biomarkers 61 trans splicing 61 IgG antibodies 61 CCR5 inhibitors 61 Fc receptor 61 ESBLs 61 Novartis Gleevec 61 VEGF receptor 61 HuLuc# 61 therapeutic antibody 61 Symadex 61 nanomedicines 61 mucosal immunity 61 Fibroblast Growth Factor Receptor 61 TH# cells 61 aptamer 61 transfection reagent 61 effector function 61 rifamycins 61 prophylactic vaccine 61 Streptomyces bacteria 61 selective inhibition 61 immunotherapeutic 61 virulence factors 61 LEX System 61 EGF receptor 61 biomarker identification 61 rxRNA TM compounds 61 Cytolin R 61 sequence homology 61 HIV protease 61 isotype 61 myelofibrosis polycythemia vera 61 anti CD# antibody 61 IgG4 61 fatty acid biosynthesis 61 druggable targets 61 nanomolar range 61 lymphoid organs 61 glycolipids 61 botulinum neurotoxin 61 flavopiridol 61 tetravalent 61 mTOR inhibitors 61 therapeutic regimens 61 nanoviricide 61 AVI NEUGENE 61 Cyclosert 61 immunomodulatory properties 61 immune modulators 61 C. jejuni 61 glycopeptides 61 AMN# [001] 61 imatinib Gleevec 61 rxRNA 61 VEGF inhibitors 61 proteins peptides 61 NEUGENE antisense 61 nucleoside 61 calcineurin inhibitors 61 intranasal delivery 61 Raltegravir 61 serine threonine kinases 61 fluconazole resistant 61 antitumoral 61 Th# 61 adeno associated viruses 61 neutralizing antibodies 61 Human cl 61 humanized monoclonal 61 oral antiviral 61 serogroup B 61 CD8 T cell 61 direct thrombin inhibitors 61 polyketides 61 protein kinase inhibitor 61 CHO cells 61 deacetylase inhibitors 61 EGFR inhibitors 61 IFN alpha 61 HDACi 61 cytotoxic effects 61 carbohydrate polymers 61 P#X# 61 Dapagliflozin 61 CCR9 61 VitiGam 61 PKM2 61 ALK inhibitors 61 bispecific antibody 61 synergistic combinations 61 recombinant subunit vaccine 61 Kinase inhibitors 61 polypeptides 61 kinase inhibition 61 Lenocta 61 tranilast 61 AAV vector 61 VAX# 61 humanized anti 61 BCR ABL inhibitors 61 pegylated 61 panobinostat 61 anionic backbone 61 DiLA2 61 trastuzumab Herceptin 61 CDDO Im 61 predictive biomarkers 61 GPx 61 GRN#L 61 siRNAs 61 epitopes 61 NS#/#A protease 61 mycobacterial 61 antisense molecules 61 Nanobody 61 Viprovex TM 61 HDACs 61 chemotherapeutic agents 61 immunotherapies 61 M2 subunit 61 shRNA libraries 61 DOS# 61 tRNA synthetases 61 rBChE 61 L. pneumophila 61 orphan GPCRs 61 OHR/AVR# 61 enzymatically active 61 HER2 receptors 60 poliovirus vaccine 60 chemopreventive agents 60 aminoglycosides 60 exosome 60 secretory pathway 60 HCV protease 60 EphA2 60 beta lactams 60 cytotoxic 60 drug conjugate 60 integrase 60 adenoviral vector 60 Intravenous CP 60 MetaChip 60 Galectins 60 T#I mutant 60 Zolinza 60 enzyme inhibitors 60 poxviruses 60 clonally 60 OncoVEX GM CSF 60 capsular polysaccharide 60 quasispecies 60 nanobodies 60 trivalent influenza vaccine 60 Novavax VLP vaccine 60 hedgehog pathway 60 endogenous ligands 60 HIV protease inhibitors 60 N. gonorrhoeae 60 rhIL 7 60 NNRTIs 60 potent inhibitors 60 antithrombotic agents 60 protease inhibitors 60 mda 7 60 cyclophilin D 60 telomerase inhibitor 60 RiVax 60 endostatin 60 biosimilar versions 60 metabolic enzymes 60 lentivirus 60 orally bioavailable mimics 60 T#I [002] 60 antiviral therapeutics 60 cancer immunotherapy 60 insulin analogs 60 pDCs 60 amplicons 60 tumor specific antigen 60 Azedra 60 recombinant vaccine 60 CCR5 antagonists 60 immunized mice 60 HSP# inhibitors 60 ZFPs 60 non nucleoside 60 Antigenics QS 60 activin 60 epigenetic therapeutics 60 stem cell pluripotency 60 cell lysis 60 Vidofludimus 60 clade B 60 short interfering RNA 60 immunotherapeutics 60 costimulation 60 Cytotoxic 60 glioma cells 60 nucleotide analogues 60 neuroendocrine cancers 60 Pertuzumab 60 virotherapy 60 splice variant 60 reverse transcriptase inhibitors 60 Phylomer ® 60 peptidomimetic 60 pyrimidines 60 epothilones 60 MUC1 60 chimeric monoclonal antibody 60 HuCAL antibody 60 depsipeptide 60 insulin analogues 60 benzimidazole 60 protease enzyme 60 cholera toxin 60 PDGF receptor 60 ADAMTS# 60 systemically administered 60 anticancer drugs 60 selective kinase inhibitor 60 MAPCs 60 Epothilones 60 nicotinic acetylcholine receptor 60 investigational humanized monoclonal antibody 60 IAP inhibitors 60 virus AAV 60 K RAS 60 molecular assays 60 anti angiogenic agents 60 hemorrhagic fever viruses 60 ISF# 60 nifurtimox 60 immunological 60 Multimeric 60 pDNA vaccines 60 broadly neutralizing antibodies 60 Trastuzumab 60 selective orally bioavailable 60 IFNs 60 TAT# 60 mRNA sequences 60 myeloma cells 60 immunotherapy 60 Annexin A5 60 therapeutic antibodies 60 pan HDAC inhibitor 60 immunomodulatory 60 CCL# 60 enzymatic pathways 60 immunoregulation 60 preclinically 60 anti angiogenic therapies 60 anticancer compounds 60 MVA BN 60 lentiviral 60 gamma secretase inhibitors 60 Nucleic acids 60 cephalosporin antibiotics 60 single stranded oligonucleotides 60 cellular immunotherapy 60 PDE4 inhibitors 60 IgG1 antibody 60 Nedd4 60 Shiga toxin 60 IMC #B 60 irinotecan hydrochloride 60 histone deacetylase inhibitors 60 cytotoxic T lymphocyte 60 HCMV 60 LY# [003] 60 K ras mutations 60 RNAi therapeutic targeting 60 Aurora kinase 60 oxysterols 60 TRIM5a 60 PI3K inhibitor 60 corticosteroid dexamethasone 60 peptidic 60 immunotherapeutic agent 60 co stimulatory molecules 60 RNA viruses 60 epothilone 60 polynucleotide 60 Xencor XmAb 60 efavirenz Sustiva 60 receptor ligand 60 protein kinase inhibitors 60 antibody cytokine 60 protein antigens 60 dihydrofolate reductase 60 protein kinases 60 BAL# [001] 60 WT1 60 serine protease 60 mertansine 60 targeting CD# 60 CD# monoclonal antibody 60 human monoclonal antibody 60 FluCide 60 Cathepsin S 60 Aganocide 60 ActA 60 antibody reagents 60 Olaparib 60 alfa interferon 60 dengue serotype 60 neutralizing antibody responses 60 REP# 60 macrolide antibiotics 60 humoral responses 60 Civacir 60 TRV# [001] 60 antigen sparing 60 TKIs 60 antibody responses 60 PPARγ 60 ansamycin 60 tumorigenic 60 FGFR 59 hybridoma 59 herpesviruses 59 HDAC inhibition 59 antagomirs 59 JAK2 inhibitor 59 hormone gastrin 59 bovine thrombin 59 H#N# VLP vaccine 59 FUS1 59 personalized immunotherapy 59 anti EGFR antibody 59 recombinant antibody 59 viral polymerase 59 missense mutations 59 PEG SN# 59 iRGD 59 immunomodulator 59 cytoprotective 59 biodefense countermeasure 59 NKT cells 59 anti CD# monoclonal 59 anti tubercular 59 S. maltophilia 59 NS4B 59 Radezolid 59 EndoTAG TM -1 59 HCV replication 59 glioblastoma cells 59 avian H#N# 59 CD8 T cells 59 rituximab Rituxan 59 targeted antifolate 59 Interferon alfa 59 chlamydial 59 stapled peptides 59 F. tularensis 59 synthetic lethality 59 KRAS oncogene 59 meropenem 59 siRNA duplexes 59 nanoviricide drug 59 Treg cell 59 Panzem R NCD 59 mannose 59 abzymes 59 adenovirus serotype 5 59 anticancer therapy 59 interleukins 59 Cytolin ® 59 staphylococci 59 tigecycline 59 Stapled Peptide 59 Curaxin 59 DHFR 59 mtDNA mutations 59 multiplex assay 59 EGFR HER 59 IFN gamma 59 recombinant adeno associated 59 Factor IX 59 monomeric 59 assay detects 59 nonviral 59 beta lactam antibiotics 59 rxRNA ™ compounds 59 innate immune responses 59 Vaxfectin 59 VZV 59 potent cytotoxic 59 immunosuppressive regimens 59 TTR gene 59 proteases 59 therapeutic proteins 59 JAK#/JAK# 59 multiplexed assays 59 investigational monoclonal antibody 59 chemically synthesized 59 monoclonal antibody therapeutics 59 SPC# [001] 59 investigational therapies 59 S/GSK# 59 NovaBay Aganocide compounds 59 cellular cytotoxicity 59 oncolytic virus 59 carbapenem 59 EGFR antibodies 59 bactericidal activity 59 hepatoma 59 recombinant albumin 59 TNF alpha antagonist 59 5 hmC 59 VSV G 59 micro RNA 59 beta lactamases 59 chemically modified siRNA 59 Aviptadil 59 hA# 59 Protease inhibitors 59 NTDDS 59 tetravalent vaccine 59 HDAC6 59 PSMA ADC 59 Enkephalin 59 pegylation 59 Thiovir 59 milatuzumab 59 Epstein Barr virus EBV 59 antiangiogenic drugs 59 TPI ASM8 59 CCR2 59 Lassa virus 59 orally administered inhibitor 59 DsiRNA 59 GAP #B# 59 aptamers derives 59 TCAD therapy 59 monoclonal antibody MAb 59 chemotherapeutic drug 59 receptor tyrosine kinase inhibitor 59 CXCR4 59 malarial parasites 59 RNAi compounds 59 anti infective treatments 59 colony stimulating factors 59 hpSCs 59 AAV vectors 59 dsRNA 59 Carfilzomib 59 Cancer Vaccines 59 DCVax R 59 therapeutics 59 bioscavenger 59 ALV# 59 Th2 59 Elvitegravir 59 hybridomas 59 nanocarrier 59 Ramoplanin 59 AMPK activators 59 viral genome 59 hpSC 59 Japanese Encephalitis vaccine 59 synthetic analogues 59 highly immunogenic 59 PORxin TM 59 histone deacetylase inhibitor 59 EGFr 59 adult mesenchymal stem 59 Valortim R 59 anthrax toxin 59 Panzem 59 Trastuzumab DM1 59 Candida species 59 pentamidine 59 humanised monoclonal antibody 59 Hsp# inhibitors 59 ganciclovir 59 indibulin 59 ganetespib 59 Dasatinib 59 HDAC inhibitors 59 AtuRNAi 59 HQK 59 immunostimulatory 59 KRAS mutation 59 ErbB3 HER3 59 immunological diseases 59 Locked Nucleic Acid LNA 59 beta defensins 59 paramyxoviruses 59 IGF IR 59 fusion protein 59 allogeneic HSCT 59 TNF alpha inhibitors 59 Lacromin 59 Phylomer 59 biologic pathway 59 TLR9 agonists 59 tolevamer 59 soluble receptor 59 EGF receptors 59 plectasin 59 avidin 59 DepoVax ™ 59 nonvaccine 59 eflornithine 59 rituximab Rituxan ® 59 potently inhibit 59 RNA therapeutics 59 B7 H3 59 targeted radiotherapeutic 59 Typhi 59 Anticalin ® 59 dengue viruses 59 DNA methyltransferases 59 Tarvacin TM 59 DNA gyrase 59 synthetic siRNAs 59 antitumor 59 LNPs 59 CB2 receptor 59 neuraminidase inhibitor 59 PROCHYMAL 59 immunomodulation 59 GPCRs 59 Src inhibitors 59 S. pyogenes 59 RNA antagonist 59 hemagglutinin HA 59 C. neoformans 59 tyrosine kinase inhibitor 59 integrase inhibitor 59 immunoconjugate 59 ceftazidime 59 hES cells 59 immune modulator 59 receptors EGFR 59 insertional mutagenesis 59 interferon beta 59 talabostat 59 synthetic siRNA 59 thrombopoietin 59 radiolabeled monoclonal antibody 59 affinity ligands 59 pertuzumab 59 Alocrest 59 MAPK pathway 59 ApoB SNALP 59 topoisomerase 59 pathogenic viruses 59 salinomycin 59 TriRima 59 Doxorubicin 59 epitope 59 Affibody ® molecules 59 Ii protein 59 Monocytes 59 therapeutic mAbs 59 carbohydrate polymer 59 DCVax Brain 59 Radilex 59 silico prediction 59 Sphingomab 59 antiparasitic drugs 59 YONDELIS R 59 Fc fusion protein 59 miRs 59 siRNA mediated 59 Zysolin TM 59 nanoparticle formulation 59 TLR8 agonist 59 humanized monoclonal antibody 59 liposomal delivery 59 Hepatocytes 59 retroviral vectors 59 siRNA molecules 59 collagens 59 immunoglobulin G 59 virosome 58 apoptotic pathway 58 CXCL5 58 H#Y 58 antibody mediated 58 PLX cells 58 Gleevec imatinib 58 plasmid DNA 58 Pichia pastoris 58 iPSC 58 oral JAK1 58 RECOTHROM R 58 filoviruses 58 ligand TRAIL 58 nucleotide analogs 58 DNA plasmid 58 GSK3B 58 HbF 58 BanLec 58 molecular abnormalities 58 NFkB 58 interfering RNA 58 pluripotent cells 58 eTag assays 58 ERK2 58 CCR5 receptors 58 allogeneic cell 58 multivalent vaccine 58 siRNA compounds 58 recombinant polyclonal antibodies 58 pneumococcal serotypes 58 bacterial genomes 58 marketed EGFR 58 CD8 responses 58 ncRNAs 58 LHRH antagonists 58 immunochemistry 58 PEGylated interferon 58 viral hemorrhagic fevers 58 anticoagulant reversing agent 58 diagnostic biomarkers 58 immuno modulatory 58 Monoclonal Antibody 58 transgene expression 58 orally dosed 58 fluoroquinolone resistance 58 CCR5 antagonist 58 taxol 58 NXL# 58 resolvins 58 selective modulator 58 TGF ß 58 TB bacterium 58 androgen receptor AR 58 proteolytic cleavage 58 Multiferon ® 58 sporozoites 58 antisense oligonucleotide 58 favorable pharmacokinetic profile 58 CYC# 58 cytotoxic therapies 58 siRNAs targeting 58 secondary metabolites 58 chimeric antibodies 58 viral isolates 58 inhibit angiogenesis 58 dasatinib Sprycel 58 inhibitor RG# 58 Interferon Beta 58 SNALP formulation 58 diagnostic assays 58 albumin bound paclitaxel 58 antineoplastic 58 CBLC# 58 kidney urologic 58 cytolytic 58 membrane receptors 58 SynCon 58 purified recombinant 58 IMC A# 58 DAS# [001] 58 biodefense pathogens 58 porcine derived 58 p# activation 58 myeloproliferative disorders 58 therapeutically relevant 58 p# inhibitor 58 vinca alkaloids 58 lipases 58 glycoproteins 58 mature dendritic cells 58 BRAF inhibitor 58 miRNAs 58 metaglidasen 58 Gefitinib 58 Altastaph 58 cytotoxin 58 macrolides 58 MVA BN ® 58 tRNA synthetase 58 TACI Ig 58 TKM ApoB 58 nucleases 58 IgG1 antibodies 58 chemotherapeutic treatments 58 tyrosine kinase inhibitors 58 Ridaforolimus 58 recombinant plasma 58 shRNAs 58 Aliskiren 58 synthetic peptide 58 Tissue Factor 58 infected macrophages 58 chemotherapeutic drugs 58 GeoVax vaccine 58 orally bioavailable 58 protein tyrosine phosphatase 1B 58 N Myc 58 Marburg viruses 58 PGL# 58 cMET 58 4CMenB 58 FluChip 58 ChronVac C R 58 pyrimethamine 58 neuroblastoma tumors 58 liposomal 58 chemokine receptors 58 anti CD3 antibody 58 Velcade bortezomib 58 surface proteins hemagglutinin 58 PTP 1B 58 HIV integrase inhibitors 58 bacterial toxins 58 intradermal injection 58 Estrogen Receptor 58 Liprotamase 58 EndoTAG 58 Medarex UltiMAb R 58 tuberculosis bacterium 58 Maribavir 58 NITD# 58 EGFRvIII 58 gastrointestinal stromal tumors GISTs 58 neuraminidase inhibitors 58 Anthim 58 ETBs 58 glycan 58 siderophores 58 RhuDex ® 58 bryostatin 58 Umbilical cord stem cells 58 autoreactive 58 IGF 1R 58 secrete proteins 58 HepaGam B 58 Gamunex C 58 proliferative disorders 58 BioVant 58 interferon alpha 58 oral prodrug 58 cisplatin resistant 58 isoform selective 58 Preclinical studies suggest 58 recombinant fusion 58 BRAF inhibitors 58 Archexin 58 lipid nanoparticles 58 diagnostic biomarker